Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received its first round of purchase orders in the United Kingdom (UK) for its antimicrobial wash, C-Scrub Wash Chlorhexidine 4% ('C-Scrub'), exceeding $500,000. The orders cover the period from July 2024 to September 2024.
阿童木健康公司（"阿童木健康" 或 "公司''） （纳斯达克：COSM），一个多元化、垂直整合的全球医疗集团，致力于创新研发，拥有专有药品和营养品品牌，生产和分销医疗产品，并经营一家远程医疗平台。今天宣布，该公司已收到在英国（英国）购买其抗菌洗涤液C-Scrub 氯己定4% ('C-Scrub') 的首批订购，订单金额超过50万美元。这些订单涵盖了2024年7月至2024年9月的区间。
Cosmos Health is in the process of securing additional orders for October 2024 and beyond. Given the high profit margins associated with C-Scrub, the Company anticipates substantial profitability from these orders. The shipments will supply various entities in the UK as part of the Company's comprehensive sales strategy, targeting a diverse range of customers, including hospitals and wholesalers. Additionally, the Company reaches consumers directly through its online stores on platforms such as Amazon, TikTok, and eBay.
阿童木健康正在努力确保在2024年10月及以后获得额外订单。鉴于C-Scrub 带来的高利润率，公司预计将从这些订单中获得可观的利润。这些货物将供应英国的各个单位，作为公司全面销售策略的一部分，针对多样化的客户群，包括医院和批发商。此外，公司还通过亚马逊、TikTok 和 ebay 等平台的在线商店直接接触消费者。